Since mTOR pathway was commonly over-activated and promoted cell invasion and metastasis in NPC, rapamycin treatment was supposed to reduce EMT and invasion ability in both NC and miR-18a-expressing groups (as shown in Fig. 4b, c)25. Here, MTOR is linked to nasopharyngeal carcinoma.